Evrim Alyamac Dizdar Selected Research

beractant (Survanta)

6/2014	Neurodevelopmental outcomes of very low birth weight preterm infants treated with poractant alfa versus beractant for respiratory distress syndrome.
2/2012	A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evrim Alyamac Dizdar Research Topics

Disease

3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2014 - 09/2011
2	Bronchopulmonary Dysplasia 02/2012 - 12/2011
2	Necrotizing Enterocolitis 01/2011 - 10/2009
1	Birth Weight (Birth Weights) 02/2022
1	Labor Pain 07/2014
1	Hemorrhage 02/2014
1	Cysts 02/2012
1	Invasive Fungal Infections 05/2011
1	Body Weight (Weight, Body) 05/2011
1	Intestinal Fistula 10/2009

Drug/Important Bio-Agent (IBA)

2	poractant alfa (Curosurf)FDA Link 06/2014 - 02/2012
2	beractant (Survanta)FDA Link 06/2014 - 02/2012
1	Proteins (Proteins, Gene)FDA Link 07/2014
1	Ibuprofen (Motrin)FDA LinkGeneric 02/2014
1	Clarithromycin (Biaxin)FDA LinkGeneric 12/2011
1	Surface-Active Agents (Surfactants)IBA 09/2011
1	Oxidants (Oxidizing Agents)IBA 09/2011
1	AntioxidantsIBA 09/2011
1	Nystatin (Mycostatin)FDA LinkGeneric 05/2011
1	SuspensionsIBA 05/2011
1	Fluconazole (Zonal)FDA LinkGeneric 05/2011
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2011

Therapy/Procedure

1	Mechanical Ventilators (Ventilator) 02/2022
1	Continuous Positive Airway Pressure 02/2022
1	Intermittent Positive-Pressure Ventilation 02/2022
1	Therapeutics 02/2012
1	Operative Surgical Procedures 10/2009